Rapt Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In South San Franciscocaliforniathe Company Focuses On Discoveringdevelopingand Commercializing Innovative Therapies For Inflammatory And Immunologic Diseasesas Well As Oncologyrapt Therapeutics Utilizes Its Expertise In Immunology To Create Therapies That Modulate Immune Responses Critical To These Conditions Founded As Flx Biothe Company Rebranded In 2018 To Emphasize Its Drug Discovery Platform For Ccr4 Antagonists And Dual Ccr4 Ccr8 Antagonistsrapt Therapeutics Went Public In 2019Which Helped Secure Funding For Its Development Pipelinethe Company S Product Pipeline Includes Rpt193A Ccr4 Antagonist For Inflammationflx475Zelinapant A Dual Ccr4 Ccr8 Antagonist For Oncologyand A Novel Long Acting Anti Ige Antibody For Food Allergies And Other Ige Mediated Diseasesrapt Therapeutics Is Dedicated To Advancing Therapies That Address Significant Unmet Medical Needs
No conferences found for this company.
| Company Name | Rapt Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
